Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−84.11 MTWD
24.59 MTWD
30.90 M
About UNICOCELL BIOMED CO LTD
Sector
Industry
CEO
Chia Chu Tsai
Website
Headquarters
Taipei
Founded
2018
ISIN
TW0006794001
FIGI
BBG00YJWNK68
UnicoCell Biomed Co., Ltd. is a biomedical company that mainly focuses on the development of stem cell therapeutic product, cell therapy technology, and regenerative medicine applications. It offers ELIXCYTE is an allogeneic adipose stem cell product for the treatment of knee osteoarthritis and chronic kidney disease and CT31-ELIXCYTE is a product for treatment of renal failure. The company was founded on March 28, 2018 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6794 is 81.0 TWD — it has decreased by 0.49% in the past 24 hours. Watch UNICOCELL BIOMED CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange UNICOCELL BIOMED CO LTD stocks are traded under the ticker 6794.
6794 stock has fallen by 5.48% compared to the previous week, the month change is a 19.12% rise, over the last year UNICOCELL BIOMED CO LTD has showed a 19.12% increase.
6794 reached its all-time high on May 27, 2024 with the price of 88.0 TWD, and its all-time low was 68.0 TWD and was reached on May 21, 2024. View more price dynamics on 6794 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6794 stock is 4.60% volatile and has beta coefficient of 0.13. Track UNICOCELL BIOMED CO LTD stock price on the chart and check out the list of the most volatile stocks — is UNICOCELL BIOMED CO LTD there?
Yes, you can track UNICOCELL BIOMED CO LTD financials in yearly and quarterly reports right on TradingView.
UNICOCELL BIOMED CO LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
6794 earnings for the last quarter are −0.31 TWD per share, whereas the estimation was −0.31 TWD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.35 TWD per share. See more details about UNICOCELL BIOMED CO LTD earnings.
UNICOCELL BIOMED CO LTD revenue for the last quarter amounts to 2.67 M TWD, despite the estimated figure of 2.67 M TWD. In the next quarter, revenue is expected to reach 6.29 M TWD.
6794 net income for the last quarter is −31.51 M TWD, while the quarter before that showed −24.91 M TWD of net income which accounts for −26.52% change. Track more UNICOCELL BIOMED CO LTD financial stats to get the full picture.
No, 6794 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6794 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNICOCELL BIOMED CO LTD stock right from TradingView charts — choose your broker and connect to your account.